References
Matsuda Y, Kure S, Ishiwata T (2012) Nestin and other putative cancer stem cell markers in pancreatic cancer. Med Mol Morphol 45:59–65
Janikova M, Skarda J, Dziechciarkova M et al (2010) Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154:321–326
Ryuge S, Sato Y, Wang GQ et al (2011) Prognostic significance of nestin expression in resected non-small cell lung cancer. Chest 139:862–869
Skarda J, Kolar Z, Janikova M et al (2012) Analysis of the prognostic impact of nestin expression in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156:135–142
Kruger K, Stefansson IM, Collett K, Arnes JB, Aas T, Akslen LA (2012) Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer. Breast (in press)
Piras F, Ionta MT, Lai S et al (2011) Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer. Eur J Histochem 55:e39
Sato A, Ishiwata T, Matsuda Y et al (2012) Expression and role of nestin in human cervical intraepithelial neoplasia and cervical cancer. Int J Oncol 41:441–448
Qin Q, Sun Y, Fei M et al (2012) Expression of putative stem marker nestin and CD133 in advanced serous ovarian cancer. Neoplasma 59:310–315
Author information
Authors and Affiliations
Corresponding author
Additional information
An answer to this letter to the editor is available at doi:10.1007/s00795-013-0023-2.
Rights and permissions
About this article
Cite this article
Kapoor, S. Nestin and its emerging role in tumor progression and carcinogenesis in systemic tumors besides pancreatic carcinomas. Med Mol Morphol 46, 56–57 (2013). https://doi.org/10.1007/s00795-013-0022-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00795-013-0022-3